You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 7, July 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Note
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (12)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Neoplasms of Head & Neck
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Fanconi Anemia

Adult Head and Neck Cancer and Hematopoietic Mosaicism

Blanche P. Alter, MD, MPH; Hans Joenje, PhD; Anneke B. Oostra; Gerard Pals, PhD

Arch Otolaryngol Head Neck Surg. 2005;131:635-639.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Fanconi anemia (FA) is an autosomal recessive DNA repair disorder with a very high risk of cancer.1-2 While most of the homozygotes are identified clinically because of characteristic birth defects and early-onset aplastic anemia,3 a subset of patients, often with milder physical and hematologic phenotypes, remain undiagnosed. They are at very high risk of neoplasms, including acute myeloid leukemias and solid tumors.4 All types of solid tumors (combined) develop at a rate that is 48 times greater than that experienced by the general population, and the cancer hazard rate is 2% per year by the age of 24 years, with a cumulative incidence in a competing risk model of 29% by the age of 45 years.5

The majority of the solid tumors in patients with FA arise in the aerodigestive or gynecologic areas.3, 6 The relative risk . . . [Full Text of this Article]

REPORT OF A CASE

METHODS

RESULTS

COMMENT

AUTHOR INFORMATION

Author Affiliations: Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, Md (Dr Alter); and Department of Clinical Genetics and Human Genetics, VU University Medical Center, Amsterdam, the Netherlands (Drs Joenje and Pals and Ms Oostra).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLE

Head and Neck Squamous Cell Carcinoma in Patients With Fanconi Anemia
Carter Van Waes
Arch Otolaryngol Head Neck Surg. 2005;131(7):640-641.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita
Alter et al.
Blood 2007;110:1439-1447.
ABSTRACT | FULL TEXT  

Diagnosis, Genetics, and Management of Inherited Bone Marrow Failure Syndromes
Alter
ASH Education Book 2007;2007:29-39.
ABSTRACT | FULL TEXT  

Molecular biology of squamous cell carcinoma of the head and neck.
Perez-Ordonez et al.
J. Clin. Pathol. 2006;59:445-453.
ABSTRACT | FULL TEXT  

Head and Neck Squamous Cell Carcinoma in Patients With Fanconi Anemia
Van Waes
Arch Otolaryngol Head Neck Surg 2005;131:640-641.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.